Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing 
Zhipu AI Stock Jumps on Report of Custom AI Chip Development Plans 
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership 
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft 
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom 
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
Alphabet Inc. is preparing to separate its life sciences subsidiary, Verily, in what could lead to a full sale or spinoff, according to recent testimony in a federal antitrust trial against Google. The move, revealed in court by Heather Adkins, Google’s Vice President of Security Engineering, marks the first public confirmation that Alphabet intends to divest Verily from its corporate structure.
Speaking in a Virginia courtroom, Adkins explained that Verily has been transitioning its operations from Google’s internal infrastructure to Google Cloud Platform for more than two years. This effort aims to make Verily technologically independent, a crucial step for any potential sale or spinoff. “We are in the process of helping them become an independent company,” Adkins stated. “The idea is to have it no longer be an Alphabet entity.”
Verily, launched as part of Alphabet’s push into health sciences, focuses on developing digital health solutions, data-driven research tools, and technologies that improve patient care. While Alphabet has previously worked to reduce Verily’s reliance on Google systems, Thursday’s testimony represents the clearest signal yet that Alphabet is preparing to cut ties with the unit.
The separation comes as Alphabet faces increased scrutiny over its dominance in digital advertising. The Justice Department’s case against Google centers on alleged monopolistic practices, and Adkins’ testimony offered a rare glimpse into Alphabet’s broader restructuring plans.
If Verily is spun off or sold, the move could reshape Alphabet’s portfolio by narrowing its focus on core businesses such as Google Search, YouTube, and cloud services, while positioning Verily to attract independent investors and partnerships in the rapidly growing health technology sector.
The potential spinoff underscores Alphabet’s evolving strategy of streamlining its business while allowing innovative subsidiaries like Verily to pursue independent growth paths in competitive industries.
